Skip to main content
SpringerLink
Log in

ADT not linked to excess CV mortality in prostate cancer

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK.Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA: the Journal of the American Medical Association 306: 2359-66, No. 21, 7 Dec 2011. Available from: URL: http://dx.doi.org/10.1001/jama.2011.1745

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ADT not linked to excess CV mortality in prostate cancer. React. Wkly. 1383, 4 (2012). https://doi.org/10.2165/00128415-201213830-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213830-00010

Keywords

Search

Navigation